By Professor Ric Day

Journal articles

Day RO, 1981, 'Effects of exercise performance on drugs used musculoskeletal disorders', Medicine and Science in Sports and Exercise, 13, pp. 272 - 275, http://dx.doi.org/10.1249/00005768-198104000-00013

Day RO; Dromgoole SH; Furst DE; Hignite C; Paulus HE, 1981, 'Formation of methyl ester of salicyluric acid during quantitation of salicyluric acid in urine by high‐pressure liquid chromatography', Journal of Pharmaceutical Sciences, 70, pp. 1090 - 1092, http://dx.doi.org/10.1002/jps.2600700934

Day RO; Furst DE; Dromgoole SH, 1981, 'Naproxen serum level response relationship in rheumatoid arthritis', Australian and New Zealand Journal of Medicine, 11, pp. 720

Furst DE; Day RO; Dromgoole SH, 1981, 'Steady-state serum level vs response relationship for naproxen in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, 29, pp. 247

Day RO; Lindsley HB, 1979, 'Rational use of aspirin and nonsteroidal anti-inflammatory drugs in inflammatory arthritis.', Journal of the Kansas Medical Society, 80, pp. 155 - 159

Champion GD; Day RO; Paull PD, 1979, 'Clinical pharmacology and efficacy of benorylate in patients with rheumatoid arthritis', Current Therapeutics, 20, pp. 145

Day RO, 1979, 'DEAFNESS DUE TO ASPIRIN', Journal of Clinical Pharmacology, 19, pp. 328 - 328, http://dx.doi.org/10.1002/j.1552-4604.1979.tb02488.x

Day R; Shen D; Azarnoff D, 1979, 'Decline of steady-state serum salicylate in rheumatoid arthritics given high-dosage salicylate therapy', Clinical Pharmacology and Therapeutics, 25, pp. 220 - 221

Day RO; Shen DD; Azarnoff DL, 1979, 'Effect of high-dosage salicylate therapy on average steady-state serum salicylate and formation of salicylurate in patients with rheumatoid arthritis', Clinical Research, 27, pp. 230

RAY JE; WADE DN; GRAHAM GG; DAY RO, 1979, 'Pharmacokinetics of Carprofen in Plasma and Synovial Fluid', Journal of Clinical Pharmacology, 19, pp. 635 - 643, http://dx.doi.org/10.1002/j.1552-4604.1979.tb01626.x

Graham G; Champion GD; Day RO, 1979, 'The pharmacokinetics of salicyclate in patients with rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 6, pp. 194

Day RO; Wade DN, 1978, 'Influence of flufenamic acid and calcium ion concentration on the histamine release from rat mast cells induced by compound 48/80 and the calcium ionophore A23187', Biochemical Pharmacology, 27, pp. 1385 - 1387, http://dx.doi.org/10.1016/0006-2952(78)90126-0

Champion GD; Day RO; Paull PD; Graham GG; Owen MS; Haski AL; Hills L, 1978, 'Clinical Pharmacology and Efficacy of Benorylate in Patients with Rheumatoid Arthritis', Australian and New Zealand Journal of Medicine, 8, pp. 22 - 28, http://dx.doi.org/10.1111/j.1445-5994.1978.tb02398.x

Day RO; Wade DN, 1978, 'EFFECTS OF VARIOUS DRUGS ON THE OSMOTIC LYSIS OF RAT MAST CELLS', Clinical and Experimental Pharmacology and Physiology, 5, pp. 477 - 485, http://dx.doi.org/10.1111/j.1440-1681.1978.tb00700.x

Day RO; Wade DN, 1978, 'THE EFFECT OF VARIOUS DRUGS ON ADENOSINE TRIPHOSPHATE CONTENT AND HISTAMINE RELEASE FROM RAT PERITONEAL CELL SUSPENSIONS RICH IN MAST CELLS', Clinical and Experimental Pharmacology and Physiology, 5, pp. 223 - 227, http://dx.doi.org/10.1111/j.1440-1681.1978.tb00675.x

Day RO; Champion GD; Wade DN, 1978, 'The effect of various drugs on compound 48/80 and osmotic shock-induced histamine release from rat peritoneal cells', Clinical and Experimental Pharmacology and Physiology, 5, pp. 241 - 242

Bowden GJ; Day RK, 1977, 'A novel low temperature rearrangement of atoms in the rare earth intermetallic compound ErFe3', Journal of Physics F Metal Physics, 7, pp. 181 - 190, http://dx.doi.org/10.1088/0305-4608/7/1/027

Bowden GJ; Day RK, 1977, 'On the magnetic anomaly in ErFe3 at 47K', Journal of Physics F Metal Physics, 7, pp. 191 - 197, http://dx.doi.org/10.1088/0305-4608/7/1/028

Graham GG; Champion GD; Day RO; Kaski AL; Hills LG; Paull PD, 1977, 'Salicylates in rheumatoid arthritis: pharmacokinetics and analgesic response.', Agents and Actions Supplements, pp. 37 - 42

Day RO; Paull PD; Ray JE; Wade DN, 1977, 'The measurement of histamine release from suspensions of rat peritoneal cells rich in mast cells', Agents and Actions, 7, pp. 431 - 436, http://dx.doi.org/10.1007/BF01966848

Day RK; Bowden GJ, 1977, 'Magnetic anomalies in ErFe3', Physica B C, 86-88, pp. 71 - 72, http://dx.doi.org/10.1016/0378-4363(77)90230-3

Graham GG; Champion GD; Day RO; Paull PD, 1977, 'Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, 22, pp. 410 - 420, http://dx.doi.org/10.1002/cpt1977224410

Grahm GG; Champion GD; Day RO, 1977, 'Salicylates in rheumatoid arthritis: Pharmacokinetics and analgesic responses', Agents and Actions, 7, pp. 35 - 42

Champion GD; Day RO; Fagan N, 1977, 'Single dose comparison of analgesic action of acetylsalicylate and sodium salicylate in rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 4, pp. 213

Champion GD; Corrigan AB; Day RO, 1977, 'The effect of enteric coating of aspirin tablets on occult gastrointestinal blood loss', Clinical and Experimental Pharmacology and Physiology, 4, pp. 214 - 215

Day RO; Ray JE; Champion GD; Wade DN, 1977, 'The effect of non steroidal anti inflammatory drugs on ATP levels and histamine release from rat peritoneal cell suspension rich in mast cells', Clinical and Experimental Pharmacology and Physiology, 4, pp. 212 - 213

CHAMPION GD; DAY RO; RAY JE; WADE DN, 1977, 'THE EFFECT OF NON‐STEROIDAL ANTI‐INFLAMMATORY DRUGS ON ADENOSINE TRIPHOSPHATE CONTENT AND HISTAMINE RELEASE FROM RAT PERITONEAL CELL SUSPENSIONS RICH IN MAST CELLS', British Journal of Pharmacology, 59, pp. 29 - 33, http://dx.doi.org/10.1111/j.1476-5381.1977.tb06973.x

Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG, 1977, 'The Effects of Enteric Coating of Aspirin Tablets on Occult Gastrointestinal Blood Loss', Australian and New Zealand Journal of Medicine, 7, pp. 600 - 604, http://dx.doi.org/10.1111/j.1445-5994.1977.tb02315.x

Graham G; Champion GD; Day RO; Paull PD, 1977, 'The pharmacokinetics of salicylate in patients with rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 4, pp. 214

Day RO; Paull PD; Champion GD; Graham GG, 1976, 'Evaluation of an Enteric Coated Aspirin Preparation', Australian and New Zealand Journal of Medicine, 6, pp. 45 - 50, http://dx.doi.org/10.1111/j.1445-5994.1976.tb03290.x

Paull P; Day R; Graham G; Champion D, 1976, 'Single dose evaluation of a new enteric coated aspirin preparation', Medical Journal of Australia, 1, pp. 617 - 619, http://dx.doi.org/10.5694/j.1326-5377.1976.tb140908.x

Paull PD; Day RO; Graham GG; Champion GD, 1975, 'Bioavailability of enteric coated aspirin', Clinical and Experimental Pharmacology and Physiology, 2, pp. 442

CHAMPION GD; DAY RO; GRAHAM GG; PAULL PD, 1975, 'Salicylates in Rheumatoid Arthritis', Clinics in Rheumatic Diseases, 1, pp. 245 - 265, http://dx.doi.org/10.1016/s0307-742x(21)00120-x

Conference Papers

Chroinin DN; Premachandra K; Aung E; Girgis L; Day R; Penglase R; Refaat S; Napit S, 2025, 'Comparison of older and younger hospitalised patients with gout: A retrospective chart review', in AUSTRALASIAN JOURNAL ON AGEING, WILEY

Wabe N; Huang G; Silva S; Nguyen A; Seaman K; Raban MZ; Gates P; Day R; Close J; Lord S; Westbrook J, 2024, 'Patterns of Fall-Risk Increasing Drugs (FRIDs) Use and Associations with Falls in Residential Aged Care: A Group-Based Multi-Trajectory Analysis of An 8-Year Longitudinal Cohort Study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, pp. 44 - 45

Wright D; Michael T; Chan J; Coleshill M; Aslani P; Hughes D; Day R; Stocker S, 2024, 'Patterns of suboptimal allopurinol implementation: impact on gout outcomes', in INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, SPRINGER, pp. 339 - 339

Michael T; Chan J; Wright D; Coleshill M; Aslani P; Hughes D; Day R; Stocker S, 2023, 'Patient-led urate self-monitoring to improve allopurinol persistence and clinical outcomes in people with gout: a pilot study', in BRITISH JOURNAL OF PHARMACOLOGY, WILEY, SCOTLAND, Glasgow, pp. 288 - 290, presented at 19th World Congress of Basic and Clinical Pharmacology (WCP), SCOTLAND, Glasgow, 02 July 2023 - 07 July 2023

Michael T; Spragg J; Aslani P; Coleshill M; Chan JS; Day R; Stocker S, 2023, 'Optimising adherence to allopurinol through patient-led self-monitoring urate concentrations: gaining gout patient perspectives', in INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, SPRINGER

Selvadurai D; Aung E; Coleshill M; Briggs N; Schulz M; Day R, 2023, 'PATIENT FACTORS AND HEALTH OUTCOMES ASSOCIATED WITH ILLNESS PERCEPTIONS IN PEOPLE WITH GOUT', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 18 - 18

Tiku A; Boudville N; Brown F; Cass A; Clarke P; Day R; de Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Pascoe E; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S; Dalbeth N, 2021, 'Urate-lowering Therapy for Prevention of Gout: Prespecified Analyses from the CKD-FIX Trial', in ARTHRITIS & RHEUMATOLOGY, WILEY, pp. 1372 - 1373, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000744545202187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mao C; Coleshill M; Day RO; Aung E, 2021, 'ADHERENCE TO URATE LOWERING THERAPY AMONG PEOPLE WITH GOUT IN AUSTRALIA', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 49 - 49, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000651518500135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE KIDNEY FUNCTION: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200189&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aung E; Coleshill M; Schulz M; Kamel B; Stocker S; Day R, 2020, 'RECRUITING PEOPLE WITH GOUT INTO A CLINICAL TRIAL IN PRIMARY CARE: THE GAPP EXPERIENCE', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 42 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000553988700116&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Simic M; Harmer A; van der Esch M; Bennell K; Ferreira P; March L; Fransen M; Day R, 2019, 'DO NON-STEROIDAL ANTI-INFLAMMATORY DRUGS CAUSE OSTEOARTHRITIS PROGRESSION, A SYSTEMATIC REVIEW AND META ANALYSIS', in OSTEOARTHRITIS AND CARTILAGE, ELSEVIER SCI LTD, CANADA, Toronto, pp. S280 - S282, presented at OARSI World Congress on Osteoarthritis - Promoting Clinical and Basic Research in Osteoarthritis, CANADA, Toronto, 02 May 2019 - 05 May 2019, http://dx.doi.org/10.1016/j.joca.2019.02.663

Manollaras K; Nolan L; Day R; Norris R; Dear R, 2016, 'EFFICACY OF SCALP COOLING AND PHARMACOKINETICS AT THE KINGHORN CANCER CENTRE, ST VINCENT'S HOSPITAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 168 - 168, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900313&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Martinello M; Schteinman A; Alavi M; Williams K; Dore GJ; Day R; Matthews GV, 2014, 'The impact of ribavirin plasma concentration on the eficacy of the interferon-sparing regimen, sofosbuvir and ribavirin', in Antiviral Therapy, SAGE Publications, MA, Boston, pp. 127 - 132, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, http://dx.doi.org/10.3851/IMP2984

Baysari MT; Westbrook JI; Egan B; Day RO, 2013, 'Identification of strategies to reduce computerized alerts in an electronic prescribing system using a Delphi approach', in Lehmann CU; Ammenwerth E; Nøhr C (eds.), IOS Press, Amsterdam, pp. 8 - 12, http://dx.doi.org/10.3233/978-1-61499-289-9-8

Lipworth WL; Kerridge IH; Day RO, 2012, 'Evidence-based medicine, resource allocation, and the persisting problem of ethically contested outcomes', Dunedin, New Zealand, presented at New Zealand Bioethics Conference, Dunedin, New Zealand

Westbrook J; Reckmann M; Li L; Day RO, 2011, 'The effectiveness of two commercial prescribing systems to reduce medication errors in hospital', Melbourne, Australia, presented at Annual Conference of the Australasian Association for Quality in Health Care (AAQHC), Melbourne, Australia, 12 October 2011 - 14 October 2011

Baysari MT; Westbrook J; Day RO, 2011, 'Ethnographic observation as a method of investigating alert fatigue', in Proceedings of the 5th International Symposium on Human Factors Engineering in Health Informatics, Tapir Academic Press, Trondheim, Norway, pp. 71 - 76, presented at 5th Human factors engineering, Trondheim, Norway, 26 August 2011 - 27 August 2011

Back to profile page